Literature DB >> 17159766

Myocardial necrosis biomarkers after different cardiac surgical operations.

G Landoni1, F Pappalardo, M G Calabrò, F Boroli, O Sottocorna, G Aletti, G Crescenzi, A Zangrillo.   

Abstract

AIM: A high postoperative peak of cardiac Troponin I is associated to an increased risk of morbidity and mortality after cardiac operations. The aim of this study was to investigate the release of cardiac Troponin I in different cardiac surgical procedures.
METHODS: This was a prospective, single-centre study performed at the IRCCS San Raffaele Hospital in Milan, Italy. The study group consisted of 194 consecutive patients undergoing cardiac surgery. For each of them creatinkinase MB and cardiac Troponin I were assayed preoperatively, at ICU arrival, 4 h and 18 h postoperatively.
RESULTS: Different cardiac surgical procedures were characterized by different release of cardiac biomarkers (P<0.001, ANOVA test). Off-pump coronary artery bypass grafting (CABG) was associated to the smallest amount of myocardial injury while mitral valve replacement produced the largest amount of biomarkers release. Patients who suffered a postoperative cardiac event released more myocardial necrosis biomarkers than those with an uneventful course (P=0.01).
CONCLUSION: We showed that each type of cardiac operation has a peculiar amount of myocardial necrosis biomarkers: mitral valve replacement in particular is associated to the highest release of cardiac biomarkers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17159766

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  2 in total

1.  Statin pretreatment diminishes the levels of myocardial ischemia markers not only in CABG.

Authors:  José Martínez-Comendador; José Rubio Alvarez; José Benito Garcia Bengochea
Journal:  J Cardiothorac Surg       Date:  2010-12-29       Impact factor: 1.637

2.  Usefulness of postoperative high-sensitive troponin T measurement and implications for defining type 5 infarction.

Authors:  Lars Niclauss; Raymond Pfister; Dominique Delay; Piergiorgio Tozzi; Matthias Kirsch; René Prêtre
Journal:  J Card Surg       Date:  2021-11-10       Impact factor: 1.778

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.